AZN Gets FDA Nod for Fasenra Label Expansion in Rare Disease
The FDA okays AstraZenecas Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the second approved indication for…
834,434SEK
-1,18%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca PLC (AZN) Meet the Management at ESMO 2024 Conference (Transcript)
…
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind…
Astrazeneca Aktie: Enttäuschende Studienergebnisse belasten Kurs
Die Astrazeneca-Aktie gerät unter Druck, nachdem die Deutsche Bank Research ihre Einschätzung von "Halten" auf "Verkaufen" herabgestuft und das Kursziel…
AstraZeneca Shares Set For Worst Week in 14 Months on Sell Calls
AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023, after a disappointing update for the…